Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | LONP1 | P36776 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.46 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.45 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.45 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.45 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.45 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.45 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.45 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.45 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.45 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.45 |
| ▸ | PSMA5 | P28066 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10043293 | 1.00 | MAPT (0.53) | MAPTLMNALONP1SMN1; SMN2TSHR | |
| SCHEMBL7857535 | 0.88 | MAPT (0.54) | MAPTLMNALONP1SMN1; SMN2TSHR | |
| SCHEMBL329840 | 0.88 | MAPT (0.54) | MAPTLMNALONP1SMN1; SMN2TSHR | |
| SCHEMBL8186108 | 0.87 | PSMB11 (0.50) | MAPTLMNALONP1SMN1; SMN2TSHR | |
| SCHEMBL8033800 | 0.87 | MAPT (0.53) | MAPTLMNALONP1SMN1; SMN2TSHR | |
| SCHEMBL2411970 | 0.87 | MAPT (0.53) | MAPTLMNALONP1SMN1; SMN2TSHR | |
| SCHEMBL8176349 | 0.85 | LONP1 (0.46) | MAPTLMNALONP1SMN1; SMN2TSHR | |
| SCHEMBL10044937 | 0.85 | MAPT (0.51) | MAPTLMNALONP1SMN1; SMN2TSHR | |
| SCHEMBL7850086 | 0.85 | MAPT (0.51) | MAPTLMNALONP1SMN1; SMN2TSHR | |
| SCHEMBL13319446 | 0.85 | MAPT (0.51) | MAPTLMNALONP1SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2539320-A1 | A PROCESS FOR THE PREPARATION OF SUBSTITUTED PROLYL PEPTIDES AND SIMILAR PEPTIDOMIMETICS | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg (NL) | 2013-01-02 | — | — | EP | disclosed |
| US-20120329704-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PROLYL PEPTIDES AND SIMILAR PEPTIDOMIMETICS | VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIEENTENZORG (NL) | 2012-12-27 | — | — | US | disclosed |
| WO-2011103932-A1 | A PROCESS FOR THE PREPARATION OF SUBSTITUTED PROLYL PEPTIDES AND SIMILAR PEPTIDOMIMETICS | VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIËNTENZORG (NL) | 2011-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120329704-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PROLYL PEPTIDES AND SIMILAR PEPTIDOMIMETICS | NGLY1, NPR3, NPR1 | MAPT 3676/4885LMNA 2443/4885LONP1 1039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.